CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering of 10,588,236 shares of common stock at a public offering price of $17.00 per share. All of the shares are being offered by Beam Therapeutics. In addition, Beam Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,588,235 shares of common sto
IPO
via https://www.AiUpNow.com
February 11, 2020 at 06:37AM by , Khareem Sudlow
What is A.I. Up to Now?
Blogs For Gadget Lovers. Have A Great Business Idea And You're Ready To Build Your Future, But Don't Know Where To Start? Let AiUpNow Guide You.
Trending
-
#SeoTips Housecall Pro, a leading software platform for over 45,000 home service companies, has launched new features and enhancements desig...
-
#SeoTips Investor Wesley Chan has shown a knack for making very early investments into multi-billion-dollar unicorns, such as Plaid, Gusto, ...
-
#SeoTips When digital marketing and eCommerce exploded into the retail market, a considerable amount of the conversation revolved around B2C...
